Abstract: FR-PO0552
Quality Indicators in Peritoneal Dialysis at a Mexican Center: Five Years of Experience
Session Information
- Home Dialysis: Clinical Epidemiology
November 07, 2025 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Dialysis
- 802 Dialysis: Home Dialysis and Peritoneal Dialysis
Authors
- Nava-Vargas, Miriam Gabriela, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Zapopan, Mexico
- Franco Barrera, Miguel Angel, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Zapopan, Mexico
- Bailon, Jesus Noe, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Zapopan, Mexico
- Marquez, Oscar Omar, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Zapopan, Mexico
- Breien Alcaraz, Hugo Sergio, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Zapopan, Mexico
Background
Peritoneal dialysis (PD) is a modality of renal replacement therapy. Its effectiveness depends on the proper monitoring of clinical and laboratory parameters, as well as the control of infectious and cardiovascular complications. The establishment and evaluation of international targets, such as rates of peritonitis, exitsite infections, hospitalizations, and mortality, allow for the assessment of the quality of care and health outcomes in this population.
Methods
A 5-year descriptive observational study was conducted at a peritoneal dialysis center in Guadalajara, Mexico. The entire population enrolled in the peritoneal dialysis program and under follow up was included. Fourteen targets derived from various international consensus statements and guidelines established for PD patient populations were recorded, with the aim of presenting our center’s experience in terms of quality of care.
Results
Data from the years 2017, 2018, 2019, 2023, and 2024 were analyzed. We did not have records for 2020, 2021, and 2022 due to the COVID-19 pandemic. In recent years, the average mortality was 8% and hospitalization was less than 0.8 patients per month, with an average of 0.5 patient hospitalization days per month post pandemic, meeting international targets. Regarding peritonitis goals, during this period there were 0.17 episodes of peritonitis per patient year, with a 4.2% transfer rate to hemodialysis; however, cultures were negative in more than 15% of cases. However, blood pressure targets have not yet been achieved in patients.
Conclusion
Over the years, our center has met the most relevant targets for patients on peritoneal dialysis, such as mortality, hospitalization, peritonitis, and transfer to hemodialysis. This is a result of the standardized protocol of continuous training for patients and caregivers, as well as the availability of immediate care for any eventuality, both by phone and in person.